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Abstract
Background: Klebsiella pneumoniae is the major cause of community-acquired pyogenic infections in Taiwan. This
retrospective study evaluated the clinical and microbiological characteristics of bacteremic community-acquired
pneumonia due to K. pneumoniae in Taiwanese adults.
Methods: The clinical characteristics of bacteremic community-acquired pneumonia (CAP) in adults due to
K. pneumoniae were compared to those of adults with bacteremic CAP due to Streptococcus pneumoniae at a
tertiary medical center in Taiwan from 2001-2008. Risk factors for mortality of bacteremic CAP due to K.
pneumoniae were analyzed. All clinical isolates of K. pneumoniae were examined for capsular serotypes,
hypermucoviscosity phenotype, aerobactin and rmpA gene.
Results: K. pneumoniae was the dominant cause of bacteremic CAP and was associated with a more fulminant
course and a worse prognosis than bacteremic CAP due to Streptococcus pneumoniae. Initial presentation with
septic shock and respiratory failure were independent risk factors for both early and total mortality. Serotype K1
and K2 comprised around half of all isolates. There were no significant differences in the clinical characteristics of
patients with bacteremic CAP due to K1/K2 and non-K1/K2 isolates. Hypermucoviscosity phenotype as well as the
aerobactin and rmpA genes were highly prevalent in the K. pneumoniae isolates.
Conclusions: K. pneumoniae continued to be the dominant cause of bacteremic CAP in Taiwanese adults during
2001-2008. Initial presentation with septic shock and respiratory failure were independent risk factors for both early
and total mortality from K. pneumoniae bacteremic CAP. Serotypes K1/K2 comprised around half of all isolates, but
did not predispose patients to a poor clinical outcome. Physicians should be aware of the poor prognosis of any
patient with bacteremic K. pneumoniae CAP and monitor these patients more closely.
Background
Klebsiella pneumoniae i st h em a j o rc a u s eo fl i v e r
abscess, Gram-negative bacillary meningitis, brain
abscess, lung abscess, thoracic empyema, prostatic
abscess, deep neck infection and complicated skin and
soft tissue infections in Taiwan [1], and comprised 4.8%
of the common causative pathogens of community-
acquired pneumonia (CAP) in a multi-center survey [2].
Although K. pneumoniae is generally considered an
infrequent cause of CAP in the United States and
Europe, a large prospective study showed that K. pneu-
moniae was not only a frequent etiology of severe CAP,
but also an independent risk factor for mortality [3].
A number of studies have suggested that bacteremia is
a risk factor for death in patients with CAP [4-7].
Although previous studies investigated the characteris-
tics and treatment strategy for bacteremic pneumococ-
coal pneumonia, few studies of bacteremic CAP due to
K. pneumoniae have been reported and most of these
were conducted before 2000 [8-10]. In one global study,
pneumonia accounted for 29% and 62% of all cases of
community-acquired K. pneumoniae bacteremia in Tai-
wan and South Africa, respectively; however, only four
cases of community-acquired bacteremic K. pneumoniae
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Europe, or Australia [10].
The present study compared the clinical characteris-
tics of bacteremic CAP due to K. pneumoniae with the
characteristics of bacteremic CAP due to Streptococcus
pneumoniae and the virulence factors of invasive K
pneumoniae isolates in a tertiary medical center over an
8-year period in Taiwan.
Methods
Patient selection
Microbiology records were used to identify consecutive
patients with bacteremic CAP admitted between January
2001 and December 2008 at Taipei Veterans General
Hospital, a 2,900-bed tertiary medical center in northern
Taiwan. The medical records of patients with bactere-
mic CAP due to either K. pneumoniae or S. pneumoniae
were reviewed. CAP was defined as an acute lower
respiratory tract infection characterized by the following:
(1) an acute pulmonary infiltrate evident on CXR and
compatible with pneumonia, (2) confirmatory findings
of the clinical examination, and (3) acquisition of the
infection outside a hospital, long-term care facility, or
nursing home [11]. Bacteremic CAP was defined as the
presence of at least one blood culture sampled within
48 h of presentation in the hospital, yielding a pathogen
presumed to be the cause of the pneumonia [11], and
the absence of other infectious sources which could
account for the bacteremia. Patients younger than 18
years old were excluded. The diagnosis was reconfirmed
by 2 infectious diseases specialists. The institutional
review board of the Taipei Veterans General Hospital
approved this study.
Data collection and definition
The following data were collected for each patient:
demographic characteristics, underlying diseases or risk
factors, clinical variables present at admission, Acute
Physiologic and Chronic Health Evaluation (APACHE)
II score, pneumonia severity index (PSI) score [12],
laboratory data, empirical antibiotics received, chest
radiograph reports, days of hospitalization, deaths less
than 48 hrs after admission, and in-hospital death. Con-
cordant antibiotic therapy was defined as initial antibio-
tic therapy including any antibiotic to which the
infecting organism was sensitive based on the microbiol-
ogy report. The diagnosis of septic shock was based on a
systolic blood pressure of <90 mmHg and peripheral
hypoperfusion with clinical or bacteriological evidence
of uncontrolled infection. Neurologic diseases encom-
passed stroke and head injury. Chronic obstructive pul-
monary diseases, bronchiectasis, and old pulmonary
tuberculosis belonged to the subgroup of chronic lung
diseases. The outcome of bacteremic CAP was defined
as in-hospital mortality measured at 28 days after onset
of bacteremic CAP. Early mortality was defined as death
less than 48 hrs after onset of bacteremic CAP.
Microbiology laboratory procedures
The VITEK 2 system (bioMérieux, Marcy l’Etoile,
France) was used to confirm bacterial identifications.
The antimicrobial susceptibility of K. pneumoniae was
tested by the disk diffusion method and interpretations
were made according to the guidelines of the Clinical
and Laboratory Standards Institute [13].
Serotyping and detection of hypermucoviscosity
phenotype, aerobactin, and rmpA gene
All isolates of K. pneumoniae causing bacteremic CAP
were serotyped by a countercurrent immunoelectro-
phoresis method as described previously [14]. Antisera
were provided by the Gram Negative Serotyping Unit of
the Laboratory of Health Care Associated Infection
(Health Protection Agency Centre for Infections, Lon-
don). K. pneumoniae ATCC9997 (K2) was used as a
control strain. All isolates with K1 and K2 serotypes
were confirmed by PCR for serotype-specific targets
within the K1 and K2 cps clusters as described pre-
viously [15]. Using crude genomic DNA as the template,
we performed PCRs to amplify the rmpA and aerobactin
genes as described previously [16]. Strains with the
hypermucoviscosity phenotype were defined by a posi-
tive string test as described previously [16].
Statistics
Contingency data were analyzed by 2-tailed chi-square
test or Fisher’s exact test, and continuous data were
analyzed by Student’stt e s to rt h eM a n n - W h i t n e yU
test. A p value of <0.05 was considered to be statistically
significant, and all probabilities were 2-tailed. Variables
with p values of <0.10 in univariate analyses subse-
quently entered in the multivariate analysis. The multi-
variate logistic regression model was used to evaluate
the risk factors for mortality in bacteremic CAP caused
by K. pneumoniae. All statistical analyses were per-
formed with SPSS, version 15.0 for Windows (SPSS).
Results
Clinical characteristics of patients with bacteremic CAP
due to K. pneumoniae
During the study period, 95 patients with bacteremic
CAP due to either K. pneumoniae or S. pneumoniae
were identified from 148 consecutive patients with bac-
teremic CAP. Excluding two patients whose infections
were determined to be caused by polymicrobial patho-
gens mixed with S. pneumoniae, the remaining 93
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groups with K. pneumoniae or S. pneumoniae as the
causative pathogen. During the study period, bacteremic
CAP was more frequently caused by K. pneumoniae
than S. pneumoniae. The clinical characteristics of the
patients with infections caused by these two pathogens
are compared in Table 1. Patients with K. pneumoniae
infection had a significantly higher mortality rate (55.1%
vs. 27.3%, respectively, P = 0.007), a significantly higher
early mortality rate (36.7% vs. 13.6%, respectively, P =
0.011), a significantly higher prevalence of PSI Risk
Class V (89.8% vs. 61.4%, respectively, P =0 . 0 0 1 ) ,as i g -
nificantly higher prevalence of ICU admission (57.1% vs.
31.8%, respectively, P = 0.014), a significantly higher
prevalence of initial presentation with respiratory failure
(61.2% vs. 31.8%, respectively, P = 0.005), a significantly
higher prevalence of APACHE II score > 25 (71.4% vs.
29.5%, respectively, P < 0.001) and a greater likelihood
of initial presentation with septic shock (51% vs. 31.8%,
respectively, P = 0.061). None of the 49 cases of bactere-
mic CAP due to K. pneumoniae had concurrent liver
abscess or other metastatic infection. All patients with
bacteremic K. pneumoniae CAP received concordant
antibiotic treatment according to the results of suscept-
ibility testing.
Laboratory findings for bacteremic community-acquired
pneumonia due to K. pneumoniae
Table 2 compares the chest radiography and laboratory
findings between patients with bacteremic K. pneumo-
niae and S. pneumoniae CAP. Patients with bacteremic
K. pneumoniae CAP had a higher prevalence of bilateral
involvement on chest radiography (65.3% vs. 22.7%,
respectively, p < 0.001) and a lower leukocyte count
(11.6 ± 6.7 × 103/μL vs. 14.4 ± 7.4 × 103/μL, respec-
tively, P = 0.044).
Factors associated with mortality in K. pneumoniae
bacteremic CAP
The results of univariate analyses of variables related to
death in bacteremic CAP due to K. pneumoniae are listed
in Table 3. In the logistic regression analysis, initial pre-
sentation with shock (OR 16.9, 95% CI 3.0-94.4, P =
0.001) and respiratory failure (OR 13.3, 95% CI 2.3-77.6,
P = 0.004) were the only independent factors associated
with fatal outcome. Early mortality compromised two
thirds of deaths in patients with bacteremic CAP due to
K. pneumoniae. Univariate analyses of variables related to
early mortality and subsequent logistic regression analysis
revealed that initial presentation with septic shock (OR
18.9, 95% CI 3.0-118.5, p = 0.002) and respiratory failure
Table 1 Comparison of clinical characteristics of patients with bacteremic K. pneumoniae and S. pneumoniae
community-acquired pneumonia
Characteristic K. pneumoniae
(n = 49)
No. (%)
S. pneumoniae
(n = 44)
No. (%)
p-value
Age, mean years ± SE 73 ± 14 76 ± 11 0.893
Male sex 39 (79.6) 39 (88.6) 0.236
Predisposing condition or risk factor
Diabetes mellitus 17 (34.7) 11 (25) 0.309
Malignancy 14 (28.6) 11 (25) 0.698
Neurologic disorders 12 (24.5) 12 (27.3) 0.759
Chronic kidney disease stage ≧ 4 13 (26.5) 13 (29.5) 0.746
Chronic lung diseases 23 (46.9) 21 (47.7) 0.939
Liver cirrhosis 4 (8.2) 3 (6.8) 1.000
Alcoholism 5 (10.2) 1 (2.3) 0.207
Autoimmune disease 3 (6.1) 1 (2.3) 0.619
No underlying diseases 3 (6.1) 5 (11.4) 0.470
APACHE II score > 25 35 (71.4) 13 (29.5) <0.001
Days of hospitalization 28 ± 24 21 ± 15 0.929
Initial presentation with septic shock 25 (51) 14 (31.8) 0.061
Initial presentation with respiratory failure 30 (61.2) 14 (31.8) 0.005
PSI Risk Class V 44 (89.8) 27 (61.4) 0.001
ICU admission 28 (57.1) 14 (31.8) 0.014
Concurrent lung abscess 3 (6.1) 0 (0) 0.244
Early mortality (deaths ≦ 48 hrs) 18 (36.7) 6 (13.6) 0.011
In-hospital mortality 27 (55.1) 12 (27.3) 0.007
Values given as mean ± SD or No. of patients (%).APACHE, Acute Physiologic and Chronic Health Evaluation; PSI, Pneumonia Severity Index; ICU, intensive care
unit.
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only independent factors associated with early mortality.
Susceptibility testing
All 49 K. pneumoniae isolates showed uniform resis-
tance to ampicillin and susceptibility to a number
classes of antibiotics including cephalosporins, amino-
glycosides, and fluoroquinolones.
Capsular serotypes and virulence factors of K. pneumoniae
Serotypes K1 and K2 accounted for 14.3% (7/49) and
38.8% (19/49) of all K. pneumoniae isolates, respectively.
The prevalence of non K1/K2 serotypes of 23 isolates
revealed K5 (n = 3), K20 (n = 2), and unidentified type
(n = 18). There were no significant difference in the
clinical characteristics of patients with bacteremic CAP
due to K1/K2 and non-K1/K2 isolates (Table 4). All K1/
Table 3 Risk factors for mortality in bacteremic CAP caused by K. pneumoniae
Characteristic Survivors
(n = 22)
No. (%)
Non-survivors
(n = 27)
No. (%)
p-value
Age > 65 years 15 (68.2) 22 (81.5) 0.282
Male 19 (86.4) 20 (74.1) 0.288
Initial presentation with septic shock 4 (18.2) 21 (77.8) <0.001
Initial presentation with respiratory failure 7 (31.8) 23 (85.2) <0.001
APACHE II score>25 10 (45.5) 25 (92.6) <0.001
PSI Risk Class V 18 (81.8) 26 (96.3) 0.160
ICU admission 10 (45.5) 18 (66.7) 0.136
Malignancy 5 (22.7) 9 (33.3) 0.414
Diabetes mellitus 10 (45.5) 7 (25.9) 0.153
Liver cirrhosis 1 (4.5) 3 (11.1) 0.617
Chronic kidney disease stage ≧ 4 6 (27.3) 7 (25.9) 0.915
Chronic lung diseases 12 (54.5) 11 (40.7) 0.336
Neurologic disorders 7 (31.8) 5 (18.5) 0.282
Autoimmune disease 1 (4.5) 1 (3.8) 1.000
Alcoholism 2 (9.1) 3 (11.1) 1.000
No underlying diseases 1 (4.0) 2 (7.4) 0.609
Chest radiography—bilateral involment 14 (63.6) 18 (66.7) 0.825
Leucopenia
a 2 (9.1) 4 (14.8) 0.678
Thrombocytopenia 2 (9.1) 9 (33.3) 0.043
C-reactive protein, mg/dL 20.9 ± 12.1 22.7 ± 10.6 0.482
Values given as mean ± SD or No. of patients (%).
a Leucopenia was defined as leucocyte count less than 4000 × 103/μL. APACHE, Acute Physiologic and Chronic
Health Evaluation; PSI, Pneumonia Severity Index; ICU, intensive care unit.
Table 2 Comparison of chest radiography and laboratory findings of patients with bacteremic K. pneumoniae and S.
pneumoniae community-acquired pneumonia
Characteristic K. pneumoniae
(n = 49)
No. (%)
S. pneumoniae
(n = 44)
No. (%)
p-value
Chest radiography at admission
Unilateral involvement 17 (34.7) 34 (77.3) <0.001
Bilateral involvement 32 (65.3) 10 (22.7) <0.001
Cavity lesion 3 (6.1) 1 (2.3) 0.619
Initial laboratory value
Leucocyte count, × 103/μL 11.6 ± 6.7 14.4 ± 7.4 0.044
Platelet, × 103/μL 212 ± 101 196 ± 107 0.969
Albumin, g/dL 2.6 ± 0.6 2.8 ± 0.6 0.072
C-reactive protein, mg/dL 21.8 ± 11.2 24.9 ± 1.5 0.664
Serum creatinine, mg/dL 2.3 ± 1.9 2.3 ± 1.4 0.186
Total biliburin, mg/dL 1.2 ± 2.7 1.1 ± 1.3 0.809
Glucose, mg/dL 220 ± 168 208 ± 202 0.528
Values given as mean ± SD or No. of patients (%).
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lates were positive for the hypermucoviscosity pheno-
type, aerobactin and rmpA genes. Three other non-K1/
K2 isolates were neither hypermucoviscous nor positive
for aerobactin or rmpA genes. There were no statisti-
c a l l ys i g n i f i c a n td i f f e r e n c e si nt h ep r e v a l e n c eo ft h e
hypermucoviscosity phenotype, the aerobactin and
rmpA genes between the K1/K2 and non-K1/K2 isolates
P = 0.096).
Discussion
K. pneumoniae is the major cause of pyogenic infections
worldwide, especially in Taiwan [1]. The present study
further highlights the role of K. pneumoniae as a dominant
pathogen in bacteremic CAP in Taiwan. A previous inves-
tigation of bacteremic CAP in Taiwan from June 1988 to
September 1991 found that K. pneumoniae was the most
frequently isolated sole pathogen (34.1%) [9]. The present
study demonstrated that K. pneumoniae was the dominant
pathogen from cases of bacteremic CAP (33.1%) in a large
tertiary-care hospital in Taiwan between 2001 and 2008.
Though conducted in a single institute, the findings of the
present study are compatible with the previous cohort [9],
and again reflect the highly endemic nature of K. pneumo-
niae infections in Taiwan [10,17].
Previous studies in Taiwan found that approximately
40-50% of community-acquired K. pneumoniae bactere-
mia was associated with diabetes mellitus [10,18], and
patients with liver cirrhosis were more likely to develop
K. pneumoniae bacteremia [19]. In addition, bacteremic
CAP due to K. pneumoniae was significantly associated
with alcoholism [10]. However, in the present study, the
most common underlying diseases were chronic lung
diseases, which may be explained by the older age of the
study population. Diabetes, a classic risk factor for com-
munity-acquired K. pneumoniae infection, did not pre-
dispose patients to bacteremic K. pneumoniae CAP in
this study. This finding suggests that the mechanism
r e s p o n s i b l ef o rt h es u s c e p t i b i l i t yt oK. pneumoniae
infection may be different for bacteremic CAP than for
other clinical manifestations, such as liver abscess.
Further study is needed to define the risk factors which
predispose patients to the development of bacteremic
K. pneumoniae CAP.
There has been limited study of clinical characteristics
of bacteremic K. pneumoniae CAP in the last decade. In
this study, we found that the severity of CAP and the
prevalence of bilateral involvement on chest X-ray were
significantly greater in patients with bacteremic K. pneu-
moniae CAP. Patients with bacteremic K. pneumoniae
Table 4 Relation of K. pneumoniae serotype to clinical characteristics
Characteristic Serotype K1,
n=7
No. (%)
Serotype K2,
n=1 9
No. (%)
Serotype non-K1/K2,
n=2 3
No. (%)
p-value
a
Age > 65 years 5 (71.4) 14 (73.7) 18 (78.3) 0.674
Male sex 4 (57.1) 15 (78.9) 20 (87) 0.229
Underlying disease or risk factor
Malignancy 1 (14.3) 5 (26.3) 8 (34.8) 0.365
Diabetes mellitus 5 (71.4) 6 (31.6) 6 (26.1) 0.234
Liver cirrhosis 0 (0) 2 (10.5) 2 (8.7) 1.000
Chronic kidney disease stage ≧ 4 1 (14.3) 5 (26.3) 7 (30.4) 0.560
Chronic lung diseases 2 (28.6) 10 (52.6) 11 (47.8) 0.907
Neurologic disorders 3 (42.9) 2 (10.5) 7 (30.4) 0.363
Autoimmune disease 0 (0) 2 (10.5) 1 (4.3) 1.000
Alcoholism 1 (14.3) 2 (10.5) 2 (8.7) 1.000
CXR–bilateral involvement 6 (85.7) 12 (63.2) 14 (60.9) 0.539
Leucopenia
b 1 (14.3) 3 (15.8) 2 (8.7) 0.671
Concurrent lung abscess 0 (0) 2 (10.5) 1 (4.3) 1.000
Initial presentation with septic shock 4 (57.1) 10 (52.6) 11 (47.8) 0.674
Initial presentation with respiratory failure 4 (57.1) 12 (63.2) 14 (60.9) 0.962
APACHE-II score > 25 5 (71.4) 15 (78.9) 15 (65.2) 0.365
PSI Risk Class V 7 (100) 17 (89.5) 20 (87) 0.655
ICU admission 3 (42.9) 12 (63.2) 13 (56.5) 0.934
Early deaths ≦ 48 hrs 3 (42.9) 7 (36.8) 8 (34.8) 0.790
In-hospital death 4 (57.1) 11 (57.9) 12 (52.2) 0.698
Values given as No. of patients (%).
aSerotype K1/K2 vs. Serotype non-K1/K2.
bLeucopenia was defined as leucocyte count less than 4000 × 103/μL. APACHE, Acute Physiologic and Chronic Health Evaluation; PSI, Pneumonia Severity Index,
ICU: intensive care unit.
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infected with S. pneumoniae. Knowledge of the different
characteristics of K. pneumoniae and S. pneumoniae
bacteremic CAP is of great importance for physicians in
endemic areas such as Taiwan. It is also vital for the
medical community in which physicians are constantly
faced with the diagnostic and prognostic challenges of
CAP patients with uncommon pathogens. A previous
study found patients infected with K. pneumoniae had
increased frequency of lower platelet count, leucopenia,
higher serum albumin, and male sex [8]. The lower leu-
cocyte count of patients with K. pneumoniae bacteremic
CAP in the present study is consistent with these
findings.
A study of ICU cases with bacteremic CAP in South
Africa from January 1982 through July 1985 found that
mortality rate was 80% in patients with K. pneumoniae
infections and 67% in patients with S. pneumoniae infec-
tions [8]. Another study from 1996 through 1997 found
that death rates from bacteremic CAP due to K. pneu-
moniae were 54% in Taiwan and 56% in South Africa
[10]. Mortality rate from bacteremic CAP due to
K. pneumoniae remained high (55%) in this study
despite advances in antimicrobial agents and supportive
care. The independent risk factors for mortality from
bacteremic CAP due to K. pneumoniae in this study
were initial presentation with septic shock and respira-
tory failure. Previous study found that the first 48 hours
of evolution of CAP were critical [20] and early mortal-
ity was also high in the present study. We also found
that initial presentation with septic shock and respira-
tory failure were the only factors associated with early
mortality. A previous study found that alcoholism was a
risk factor for poor outcome of bacteremic CAP due to
K. pneumoniae [21]. However, the present study did
not find any association between specific underlying dis-
e a s es u b g r o u p sa n dm o r t a l i t yd u et oK. pneumoniae
bacteremic CAP. Physicians should be aware of the high
mortality rate in patients with bacteremic K. pneumo-
niae CAP and monitor patients more closely.
In this study, capsular serotype K1 and K2 comprised
14.3% and 38.8%, respectively, of all K. pneumoniae iso-
lates. Previous studies reported that serotypes K1 and K2
were more common in isolates from community-acquired
infections in Taiwan, South Africa, and Singapore than
from hospital-acquired isolates in these countries or else-
where [17,22]. Metastatic infection is an important com-
plication of K. pneumoniae liver abscess in Taiwan, and
certain capsular serotypes of K. pneumoniae including K1
and K2 are thought to play an important role in the devel-
opment of distal metastatic infections, generally being con-
s i d e r e dt h ep r e d o m i n a n tv i r ulent strains [22-24]. Our
previous study indicated that serotype K1 and K2 com-
prised 59% of K. pneumonaie in community-acquired
thoracic empyema or complicated parapneumonic effusion
but did not predispose patients to poor outcome com-
pared with other non-K1/K2 serotypes [25]. In the present
study, patients with K1/K2 serotype K. pneumoniae iso-
l a t e sa l s od i dn o th a v eaw o r s eo u t c o m et h a nt h o s ew i t h
non-K1/K2 serotype of K. pneumoniae isolates, and none
of the patients with bacteremic CAP due to K. pneumo-
niae developed metastatic infection. This finding suggests
that pulmonary infection with K. pneumoniae might carry
little risk for distant metastasis even in patients with
bloodstream infection. It also suggests that though sero-
types K1 and K2 were the prevalent strains in community-
acquired pulmonary infection due to K. pneumonia, sero-
types were not related to the clinical characteristics and
prognosis. The current study found the high prevalence of
hypermucoviscosity phenotype as well as the aerobactin
and rmpA genes in K. pneumoniae isolates, which was
consistent to the previous investigation of liver abscess
strains [16]. The high frequency of coexistence of the aero-
bactin and rmpA genes in the strains causing bacteremic
CAP was in agreement with previous reports of liver
abscess strains and strains causing bloodstream infections
[16,17].
Conclusions
In conclusion, during 2001-2008, K. pneumoniae contin-
ued to be the dominant cause of bacteremic CAP in
Taiwanese adults in this tertiary-care hospital. The
K. pneumoniae bacteremic CAP had a higher mortality
than S. pneumoniae bacteremic CAP. Initial presentation
with septic shock and respiratory failure were independent
risk factors for both early and total mortality from K.
pneumoniae bacteremic CAP. Serotypes K1/K2 comprised
around half of all isolates, but did not predispose patients
to a poor clinical outcome. Physicians should be aware of
the poor prognosis of any patient with bacteremic K.
pneumoniae CAP and monitor these patients closely.
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